文献速递冠心病心力衰竭与心肌病

人心肌梗死后水肿动态反应对风险心肌及挽救评估的影响

Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage.
PubMed 文献 · Circulation · 2017-07-07

该研究通过系列心脏磁共振(CMR)评估ST段抬高型心肌梗死(STEMI)患者梗死后的水肿反应时程,并在猪模型中进行验证。结果显示梗死后水肿呈双相模式,影响CMR对风险心肌(MaR)的量化,建议在梗死后4至7天窗口进行标准化CMR评估。

要点

  • STEMI后水肿呈双相模式,影响CMR对风险心肌的评估。
  • T2加权短 tau 三反转恢复序列测量的水肿范围随CMR检查时间变化。
  • 梗死后4至7天可能是标准化CMR评估风险心肌的合适时间窗。

核心结论

  • 梗死后水肿呈双相模式,影响CMR对风险心肌的估计。
  • 动态变化强调需标准化CMR时机以回顾性界定风险心肌和量化心肌挽救。
  • 根据临床和实验数据,梗死后4至7天时间窗似乎是标准化的良好折中方案。

研究设计与样本

  • 前瞻性招募16例成功接受直接血管成形术的前壁STEMI患者和16例匹配对照。
  • 共进行94次临床CMR检查:STEMI患者在再灌注后3小时内及第1、4、7、40天系列扫描,对照仅扫描一次。
  • 实验研究对20头猪进行40分钟缺血/再灌注,并在再灌注后120分钟及第1、4、7天系列CMR检查。
  • 参考风险心肌通过冠状动脉闭塞期间的对比多排计算机断层扫描评估。
  • 使用广义线性混合模型处理重复测量。

主要发现

  • 在人类中,缺血心肌的T2弛豫时间从再灌注早期至24小时显著下降,然后至第4天增加,达到平台后从第7天下降。
  • 因此,通过T2加权短 tau 三反转恢复序列(CMR-MaR)测量的水肿范围随CMR检查时机变化。
  • 实验模型证实,仅再灌注后第4天和第7天的CMR-MaR值与参考对比多排计算机断层扫描测量的值相似。

关键数值与推荐

  • T2弛豫时间在再灌注后早期至24小时显著下降,然后至第4天增加,从第7天下降。
  • CMR-MaR值仅在再灌注后第4天和第7天与参考方法相似。
  • 梗死后4至7天时间窗被建议为标准化CMR评估的折中方案。

临床怎么用

  • 临床中应考虑CMR检查时机对风险心肌和心肌挽救评估的影响。
  • 建议在梗死后4至7天进行CMR以标准化风险心肌 delineation 和挽救量化。

局限性

  • 需要进一步研究其他因素对这些变量的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical protocols aimed to characterize the post-myocardial infarction (MI) heart by cardiac magnetic resonance (CMR) need to be standardized to take account of dynamic biological phenomena evolving early after the index ischemic event. Here, we evaluated the time course of edema reaction in patients with ST-segment-elevation MI by CMR and assessed its implications for myocardium-at-risk (MaR) quantification both in patients and in a large-animal model. METHODS: A total of 16 patients with anterior ST-segment-elevation MI successfully treated by primary angioplasty and 16 matched controls were prospectively recruited. In total, 94 clinical CMR examinations were performed: patients with ST-segment-elevation MI were serially scanned (within the first 3 hours after reperfusion and at 1, 4, 7, and 40 days), and controls were scanned only once. T2 relaxation time in the myocardium (T2 mapping) and the extent of edema on T2-weighted short-tau triple inversion-recovery (ie, CMR-MaR) were evaluated at all time points. In the experimental study, 20 pigs underwent 40-minute ischemia/reperfusion followed by serial CMR examinations at 120 minutes and 1, 4, and 7 days after reperfusion. Reference MaR was assessed by contrast-multidetector computed tomography during the index coronary occlusion. Generalized linear mixed models were used to take account of repeated measurements. RESULTS: In humans, T2 relaxation time in the ischemic myocardium declines significantly from early after reperfusion to 24 hours, and then increases up to day 4, reaching a plateau from which it decreases from day 7. Consequently, edema extent measured by T2-weighted short-tau triple inversion-recovery (CMR-MaR) varied with the timing of the CMR examination. These findings were confirmed in the experimental model by showing that only CMR-MaR values for day 4 and day 7 postreperfusion, coinciding with the deferred edema wave, were similar to values measured by reference contrast-multidetector computed tomography. CONCLUSIONS: Post-MI edema in patients follows a bimodal pattern that affects CMR estimates of MaR. Dynamic changes in post-ST-segment-elevation MI edema highlight the need for standardization of CMR timing to retrospectively delineate MaR and quantify myocardial salvage. According to the present clinical and experimental data, a time window between days 4 and 7 post-MI seems a good compromise solution for standardization. Further studies are needed to study the effect of other factors on these variables.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Fernández-Jiménez R, Barreiro-Pérez M, Martin-García A, et al. Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage. Circulation. 2017. PMID: 28687712. doi:10.1161/CIRCULATIONAHA.116.025582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。